United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2005_register
executive
2010-09-23
article
Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV
Proposed Rules
D09002ee1bde473d0
D09002ee1bde47437
United States
Department of Justice
originator
org
United States Government Agency or Subagency
United States
Drug Enforcement Administration
originator
org
United States Government Agency or Subagency
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance zopiclone, including its salts, isomers and salts of isomers into Schedule IV of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions of Schedule IV on those who handle zopiclone and products containing zopiclone.
70 FR 7449
https://www.govinfo.gov/app/details/FR-2005-02-14/05-2884
05-2884
fr14fe05-24
4410-09-P
Docket No. DEA-262P
https://www.govinfo.gov/app/details/FR-2005-02-14/05-2884
https://www.govinfo.gov/content/pkg/FR-2005-02-14/html/05-2884.htm
https://www.govinfo.gov/content/pkg/FR-2005-02-14/pdf/05-2884.pdf
Administrative Practice and Procedure
Drug Traffic Control
Narcotics
Prescription Drugs
3 p.
7449
7451
70 FR 7449
Code of Federal Regulations
Title 21 Part 1308
21 CFR Part 1308
Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV; Federal Register Vol. 70, Issue
PRORULE
05-2884
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
2005-03-16
Docket No. DEA-262P
4410-09-P
05-2884
Notice of proposed rulemaking.
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance zopiclone, including its salts, isomers and salts of isomers into Schedule IV of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions of Schedule IV on those who handle zopiclone and products containing zopiclone.
Written comments must be postmarked, and electronic comments must be sent, on or before March 16, 2005.
Christine Sannerud, Ph.D., Chief, Drug and Chemical Evaluation Section, Drug Enforcement Administration, Washington, DC 20537, (202) 307-7183.
Administrative Practice and Procedure
Drug Traffic Control
Narcotics
Prescription Drugs
Schedules of controlled substances:
Zopiclone; placement into Schedule IV,
dea.diversion.policy@usdoj.gov
http://www.regulations.gov
Federal Register
Vol. 70, no. 29
Office of the Federal Register, National Archives and Records Administration
2005-02-14
continuing
daily
deposited
born digital
266 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2005-02-14
P0b002ee18098fcf2
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr14fe05
https://www.govinfo.gov/app/details/FR-2005-02-14
https://www.govinfo.gov/content/pkg/FR-2005-02-14/pdf/FR-2005-02-14.pdf
https://www.govinfo.gov/content/pkg/FR-2005-02-14/xml/FR-2005-02-14.xml
fdlp
7379
7631
DGPO
2010-09-23
2023-05-03
FR-2005-02-14
machine generated
eng
FR
FR-2005-02-14
70
29